1 |
Abd El Ghany M, Jansen A, Clare S, Hall L, Pickard D, Kingsley RA, Dougan G. 2007. Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines. Infect. Immun. 75: 1835-1842.
DOI
|
2 |
Afonso CL, Tulman ER, Lu Z, Zsak L, Osorio FA, Balinsky C, et al. 2002. The genome of swinepox virus. J. Virol. 76: 783-790.
DOI
|
3 |
Barcena J, Blasco R. 1998. Recombinant swinepox virus expressing beta-galactosidase: investigation of viral host range and gene expression levels in cell culture. Virology 243: 396-405.
DOI
|
4 |
Benschop J, Stevenson MA, Dahl J, Morris RS, French NP. 2008. Temporal and longitudinal analysis of Danish Swine Salmonellosis Control Programme data: implications for surveillance. Epidemiol. Infect. 136: 1511-1520.
DOI
|
5 |
Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, et al. 2007. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Vaccine 25: 4996-5005.
DOI
|
6 |
DasSarma P, Negi VD, Balakrishnan A, Karan R, Barnes S, Ekulona F, et al. 2014. Haloarchaeal gas vesicle nanoparticles displaying Salmonella SopB antigen reduce bacterial burden when administered with live attenuated bacteria. Vaccine 32: 4543-4549.
DOI
|
7 |
De Ridder L, Maes D, Dewulf J, Butaye P, Pasmans F, Boyen F, et al. 2014. Use of a live attenuated Salmonella enterica serovar Typhimurium vaccine on farrow-to-finish pig farms. Vet. J. 202: 303-308.
DOI
|
8 |
Draper SJ, Heeney JL. 2010. Viruses as vaccine vectors for infectious diseases and cancer. Nat. Rev. Microbiol. 8: 62-73.
DOI
|
9 |
Ghosh S, Chakraborty K, Nagaraja T, Basak S, Koley H, Dutta S, et al. 2011. An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development. Proc. Natl. Acad. Sci. USA 108: 3348-3353.
DOI
|
10 |
Hahn J, Park SH, Song JY, An SH, Ahn BY. 2001. Construction of recombinant swinepox viruses and expression of the classical swine fever virus E2 protein. J. Virol. Methods 93: 49-56.
DOI
|
11 |
Hamid N, Jain SK. 2008. Characterization of an outer membrane protein of Salmonella enterica serovar Typhimurium that confers protection against typhoid. Clin. Vaccine Immunol. 15: 1461-1471.
DOI
|
12 |
Hong EH, Chang SY, Lee BR, Pyun AR, Kim JW, Kweon MN, Ko HJ. 2013. Intratumoral injection of attenuated Salmonella vaccine can induce tumor microenvironmental shift from immune suppressive to immunogenic. Vaccine 31: 1377-1384.
DOI
|
13 |
Lin HX, Huang DY, Wang Y, Lu CP, Fan HJ. 2011. A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein. Vaccine 29: 7027-7034.
DOI
|
14 |
Lin HX, Ma Z, Yang XQ, Fan HJ, Lu CP. 2014. A novel vaccine against porcine circovirus type 2 (PCV2) and Streptococcus equi ssp. zooepidemicus (SEZ) co-infection. Vet. Microbiol. 171: 198-205.
DOI
|
15 |
Murakami S, Ogawa A, Kinoshita T, Matsumoto A, Ito N, Nakane T. 2006. Occurrence of swine salmonellosis in postweaning multisystemic wasting syndrome (PMWS) affected pigs concurrently infected with porcine reproduction and respiratory syndrome virus (PRRSV). J. Vet. Med. Sci. 68: 387-391.
DOI
|
16 |
Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O'Brien SJ, et al. 2010. The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis. 50: 882-889.
DOI
|
17 |
Mathur R, Oh H, Zhang D, Park SG, Seo J, Koblansky A, et al. 2012. A mouse model of Salmonella typhi infection. Cell 151: 590-602.
DOI
|
18 |
Moorkamp L, Beineke A, Kaim U, Diesterbeck U, Urstadt S, Czerny CP, et al. 2008. Swinepox - skin disease with sporadic occurrence. Dtsch. Tierarztl. Wochenschr. 115: 162-166.
|
19 |
Nanton MR, Way SS, Shlomchik MJ, McSorley SJ. 2012. Cutting edge: B cells are essential for protective immunity against Salmonella independent of antibody secretion. J. Immunol. 189: 5503-5507.
DOI
|
20 |
Okamura M, Ueda M, Noda Y, Kuno Y, Kashimoto T, Takehara K, Nakamura M. 2012. Immunization with outer membrane protein A from Salmonella enterica serovar Enteritidis induces humoral immune response but no protection against homologous challenge in chickens. Poult. Sci. 91: 2444-2449.
DOI
|
21 |
Pantaleo G, Esteban M, Jacobs B, Tartaglia J. 2010. Poxvirus vector-based HIV vaccines. Curr. Opin. HIV AIDS 5: 391-396.
DOI
|
22 |
Paoletti E. 1996. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. USA 93: 11349-11353.
DOI
|
23 |
Song J, Gao X, Galan JE. 2013. Structure and function of the Salmonella Typhi chimaeric A(2)B(5) typhoid toxin. Nature 499: 350-354.
DOI
|
24 |
Penha Filho RA, Moura BS, de Almeida AM, Montassier HJ, Barrow PA, Berchieri Junior A. 2012. Humoral and cellular immune response generated by different vaccine programs before and after Salmonella Enteritidis challenge in chickens. Vaccine 30: 7637-7643.
DOI
|
25 |
Poulet H, Minke J, Pardo MC, Juillard V, Nordgren B, Audonnet JC. 2007. Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform. Vaccine 25: 5606-5612.
DOI
|
26 |
Ruggeri J, Pesciaroli M, Gaetarelli B, Scaglione FE, Pregel P, Ammendola S, et al. 2014. Parenteral administration of attenuated Salmonella Typhimurium DeltaznuABC is protective against salmonellosis in piglets. Vaccine 32: 4032-4038.
DOI
|
27 |
Strugnell RA, Scott TA, Wang N, Yang C, Peres N, Bedoui S, Kupz A. 2014. Salmonella vaccines: lessons from the mouse model or bad teaching? Curr. Opin. Microbiol. 17: 99-105.
DOI
|
28 |
Sundara Baalaji N, Mathew MK, Krishnaswamy S. 2006. Functional assay of Salmonella typhi OmpC using reconstituted large unilamellar vesicles: a general method for characterization of outer membrane proteins. Biochimie 88: 1419-1424.
DOI
|
29 |
Tripathy DN. 1999. Swinepox virus as a vaccine vector for swine pathogens. Adv. Vet. Med. 41: 463-480.
|
30 |
Winslow BJ, Cochran MD, Holzenburg A, Sun J, Junker DE, Collisson EW. 2003. Replication and expression of a swinepox virus vector delivering feline leukemia virus Gag and Env to cell lines of swine and feline origin. Virus Res. 98: 1-15.
DOI
|
31 |
Yang Y, Wan C, Xu H, Wei H. 2013. Identification and characterization of OmpL as a potential vaccine candidate for immune-protection against salmonellosis in mice. Vaccine 31: 2930-2936.
DOI
|
32 |
Winslow BJ, Kalabat DY, Brown SM, Cochran MD, Collisson EW. 2005. Feline B7.1 and B7.2 proteins produced from swinepox virus vectors are natively processed and biologically active: potential for use as nonchemical adjuvants. Vet. Microbiol. 111: 1-13.
DOI
|
33 |
Yamanouchi K, Barrett T, Kai C. 1998. New approaches to the development of virus vaccines for veterinary use. Rev. Sci. Tech. 17: 641-653.
DOI
|
34 |
Yang TC, Ma XC, Liu F, Lin LR, Liu LL, Liu GL, et al. 2012. Screening of the Salmonella paratyphi A CMCC 50973 strain outer membrane proteins for the identification of potential vaccine targets. Mol. Med. Rep. 5: 78-83.
|
35 |
Zhang Y, Bi P, Hiller JE. 2012. Projected burden of disease for Salmonella infection due to increased temperature in Australian temperate and subtropical regions. Environ. Int. 44: 26-30.
DOI
|